Advertisement

Topics

Janssen Pharmaceutical Release: New XARELTO (Rivaroxaban) Data At Congress 2017 Includes Late-Breaking Results From Landmark Phase III COMPASS Study

20:00 EDT 20 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Janssen Pharmaceutical Release: New XARELTO (Rivaroxaban) Data At Congress 2017 Includes Late-Breaking Results From Landmark Phase III COMPASS Study

NEXT ARTICLE

More From BioPortfolio on "Janssen Pharmaceutical Release: New XARELTO (Rivaroxaban) Data At Congress 2017 Includes Late-Breaking Results From Landmark Phase III COMPASS Study"

Advertisement
Quick Search
Advertisement
Advertisement